相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall et al.
CLINICAL CANCER RESEARCH (2021)
Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma
Huijuan Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients
Yutuan Wu et al.
BMC CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Samarth Hegde et al.
CANCER CELL (2020)
Immunotherapy in cervix cancer
Laura Attademo et al.
CANCER TREATMENT REVIEWS (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
Yunlong Zhao et al.
CELL REPORTS (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
M. Qorraj et al.
LEUKEMIA (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Migrating into the Tumor: a Roadmap for T Cells
Lieke L. van der Woude et al.
TRENDS IN CANCER (2017)
Dendritic cells in cancer: the role revisited
Filippo Veglia et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Immunosurveillance and immunotherapy of tumors by innate immune cells
Alexandre Iannello et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Innate immune mediators in cancer: between defense and resistance
Pedro Berraondo et al.
IMMUNOLOGICAL REVIEWS (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
Zichao Luo et al.
BIOMATERIALS (2015)
FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma
Simone Punt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity (vol 26, pg 638, 2014)
Miranda L. Broz et al.
CANCER CELL (2014)
Negative role of inducible PD-1 on survival of activated dendritic cells
Seong Jeong Park et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
Trine O. Jensen et al.
CANCER (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
NK Cells: Key to Success of DC-Based Cancer Vaccines?
Eva Lion et al.
ONCOLOGIST (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Elizabeth D. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
Eduardo J. Villablanca et al.
NATURE MEDICINE (2010)
PD-1 on dendritic cells impedes innate immunity against bacterial infection
Sheng Yao et al.
BLOOD (2009)
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
B. S. Nedergaard et al.
BRITISH JOURNAL OF CANCER (2007)
High number of intraepithelial CD8(+) tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
Sytse J. Piersma et al.
CANCER RESEARCH (2007)
An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia
Abdul Rahman Hayati et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
分享论文
